| |
| |
|
| Insider
Information: |
Keyes Jason A |
| Relationship: |
Director |
| City: |
La Jolla |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
101,944 |
|
|
Indirect Shares
|
77,720 |
|
|
| Direct
Value |
$62,016 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
179,664 |
|
|
| Total
Value |
$62,016 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orexigen Therapeutics, Inc. |
OREX |
SVP, Chief Financial O... |
2017-05-31 |
3,031 |
|
0 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Financial Officer |
2023-12-08 |
58,913 |
2023-12-08 |
77,720 |
Premium* |
|
|
Carisma Therapeutics Inc |
CARM |
Director |
2022-06-22 |
40,000 |
2022-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2023-12-08 |
4 |
A |
$0.58 |
$5,107 |
D/D |
8,805 |
58,913 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2023-06-09 |
4 |
A |
$0.56 |
$8,400 |
D/D |
15,000 |
50,108 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
A |
$1.19 |
$5,288 |
D/D |
4,444 |
35,108 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2022-08-29 |
4 |
AS |
$2.83 |
$19,810 |
I/I |
(7,000) |
77,720 |
0 |
- |
|
| CARM |
Carisma Therapeutics Inc |
Director |
– • – |
2022-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2022-06-06 |
4 |
AS |
$2.52 |
$12,600 |
I/I |
(5,000) |
84,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2022-04-04 |
4 |
AS |
$3.18 |
$25,440 |
I/I |
(8,000) |
89,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-12-10 |
4 |
A |
$2.35 |
$13,125 |
D/D |
5,585 |
23,296 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-12-01 |
4 |
AS |
$5.08 |
$25,402 |
I/I |
(5,000) |
97,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-09-27 |
4 |
AS |
$6.74 |
$53,924 |
I/I |
(8,000) |
102,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-07-27 |
4 |
AS |
$5.72 |
$28,585 |
I/I |
(5,000) |
110,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-06-10 |
4 |
A |
$2.35 |
$13,007 |
D/D |
5,535 |
17,711 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2021-05-26 |
4 |
AS |
$6.50 |
$32,484 |
I/I |
(5,000) |
115,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2020-12-23 |
4 |
AS |
$4.74 |
$37,914 |
I/I |
(8,000) |
120,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2020-12-10 |
4 |
A |
$2.35 |
$12,601 |
D/D |
5,362 |
12,176 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2020-06-10 |
4 |
A |
$2.41 |
$12,084 |
D/D |
5,014 |
6,814 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2020-02-18 |
4 |
AS |
$5.03 |
$25,138 |
I/I |
(5,000) |
130,520 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2020-01-21 |
4 |
AS |
$4.41 |
$22,043 |
I/I |
(5,000) |
135,520 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2019-09-03 |
4 |
AS |
$3.60 |
$17,981 |
I/I |
(5,000) |
138,720 |
0 |
- |
|
| EQ |
Equillium Inc |
Chief Financial Officer |
• – – |
2019-08-01 |
4 |
AS |
$3.99 |
$19,941 |
I/I |
(5,000) |
143,720 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
SVP, Chief Financial Officer |
• – – |
2017-05-31 |
4 |
A |
$1.55 |
$863 |
D/D |
557 |
3,031 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
SVP, Chief Financial Officer |
• – – |
2016-11-30 |
4 |
A |
$1.67 |
$486 |
D/D |
291 |
2,474 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
SVP, Chief Financial OfficerOf |
• – – |
2016-06-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,832 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
